Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
TRAX

First Tracks Biotherapeutics (TRAX) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $31.85 -0.5% on the day +67.6% over 12 months 52-week range $15.32 – $47.92

Share price and insider trades

TRAX closeInsider buyInsider sale
1020304050MayJunJulAugSepOctSold $1,758,287 on 2026-09-02 · J. Anthony WareSold $64,983,991 on 2026-04-20 · Ecor1 Capital, Llc
Bought, 12 months$0
Sold, 12 months$66.7M
Insiders buying0
Insiders selling2

First Tracks Biotherapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $66.7M of TRAX stock on the open market.

TRAX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $65.0M sold (1 trades)Q2 2026Q3 2026: $1.8M sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$1.8M1
Q2 2026—0$65.0M1

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 First Tracks Biotherapeutics, Inc. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $66.7M. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 4SEC J. Anthony WareDirector Sell 39,26515,660 held (−71%) $44.78 $1.8M -28.9% —
Apr 22SEC Ecor1 Capital, Llc10% Owner Sell 4,705,5753,174,519 held (−60%) $13.81 $65.0M +130.6% —

Insiders at First Tracks Biotherapeutics, Inc.

InsiderBoughtSoldLast filingScore
Ecor1 Capital, Llc10% Owner — $65.0M Apr 22, 2026 —
J. Anthony WareDirector — $1.8M Sep 4, 2026 —

TRAX stock: common questions

Are First Tracks Biotherapeutics, Inc. insiders buying TRAX stock?

In the past 12 months, 0 insiders reported open-market purchases of TRAX worth $0.

Are First Tracks Biotherapeutics, Inc. insiders selling TRAX stock?

2 insiders reported sales worth $66.7M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TRAX's 52-week range?

Over the past year TRAX has traded between $15.32 and $47.92. It last closed at $31.85 on Oct 9, 2026.